Skip to content

Zymeworks ZYME Debt securities - current

Debt securities - current at other companies

Block logo
BlockXYZ
$462.61M+30.4%
Agilon Health logo
Agilon HealthAGL
$91.42M-60.3%
General Motors logo
General MotorsGM
$4.62B-33.3%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$199.37M-42.7%
Qualys, Inc. logo
Qualys, Inc.QLYS
$191.88M+27.7%
Nike logo
NikeNKE
$1.4B-22.0%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's debt securities - current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's debt securities - current?
Zymeworks (ZYME) reported debt securities - current of $120.45M in Q1 2026.
How has Zymeworks's debt securities - current changed year-over-year?
Zymeworks's debt securities - current decreased by 36.3% year-over-year, from $189.08M to $120.45M.
What is the long-term trend for Zymeworks's debt securities - current?
Over 2 years (2023 to 2025), Zymeworks's debt securities - current has grown at a -7.0% compound annual growth rate (CAGR), from $216.77M to $187.64M.